Guest guest Posted June 20, 2008 Report Share Posted June 20, 2008 Hi folks, I have a friend whose found material on the benefits of mild thistle for PSC, including this paper: Silymarin in the Treatment of Patients with Primary Sclerosing Cholangitis: An Open-Label Pilot Study. Angulo P, nsen RA, Kowdley KV, Lindor KD. Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN, 55905, USA, angulohernandez.paul@.... No effective medical therapy is available for patients with primary sclerosing cholangitis (PSC). We evaluated the safety and estimated the efficacy of silymarin in patients with PSC in a pilot study. Thirty patients with PSC were enrolled. Silymarin, 140 mg orally three times daily, was given for 1 year. A statistically significant improvement in serum alkaline phosphatase activity (1131 +/- 216 vs. 861 +/- 139, P = 0.007), and aspartate aminotransferase (AST) levels (116 +/- 15 vs. 83 +/- 11, P = 0.01) occurred with treatment. Serum bilirubin levels were not significantly affected by the treatment, while serum albumin and the Mayo risk score remained essentially unchanged. Overall, 34% of patients had a positive response to silymarin as defined by >/=50% improvement or normal status in liver tests. The results of this pilot study warrant further evaluation of silymarin in patients with PSC in a large-scale, controlled trial. I'm surprised Dr. Lindor is on this paper, because he didn't say anything to me about it. What do you all know about it? I'm thinking of calling him to ask about it, but I assume that if he wanted me to take it, he would have done so. So why didn't he in light of this suggestive evidence? My only thought is that my liver values are currently normal, so maybe there would be no benefit? Thanks! Ruth Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.